Sialorrhea in Parkinson's Disease

Area of Science:

• Neurology
• Gastroenterology
• Otolaryngology

Background:

• Sialorrhea (excessive saliva) is a common yet underrecognized symptom in Parkinson's disease (PD).
• It significantly impacts patients' quality of life, often ranking as a top complaint.
• Existing treatments for PD-related sialorrhea are frequently suboptimal and associated with dangerous side effects.

Purpose of the Study:

• To review the anatomy, function, and causes of sialorrhea in Parkinson's disease.
• To examine the evidence supporting various treatments for sialorrhea in PD patients.
• To evaluate newer evidence on the safety and efficacy of minimally invasive treatments, specifically botulinum toxin.

Main Methods:

• Literature review of anatomical, functional, and etiological aspects of sialorrhea in PD.
• Systematic examination of clinical evidence for current sialorrhea treatments in Parkinson's disease.
• Focused review of emerging data on botulinum toxin's safety and efficacy for PD sialorrhea.

Main Results:

• Sialorrhea is a prevalent and highly bothersome symptom in Parkinson's disease.
• Current treatment options for PD sialorrhea have limitations in efficacy and safety.
• Botulinum toxin shows promise as a minimally invasive treatment with a favorable safety profile.

Conclusions:

• Understanding the pathophysiology of sialorrhea in PD is crucial for effective management.
• There is a need for safer and more effective treatments for sialorrhea in Parkinson's disease.
• Minimally invasive treatments like botulinum toxin represent a promising therapeutic avenue for PD-associated sialorrhea.